BTIG analyst Justin Zelin reiterated a Buy rating and $125.00 price target on Viking Therapeutic (NASDAQ: VKTX).The analyst comments "Viking ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Analyst Comments

Form 10-Q Viking Therapeutics, For: Sep 30October 23, 2024 5:01 PM Viking Therapeutics (VKTX) Tops Q3 EPS by 2cOctober 23, 2024 4:15 PM Form 8-K Viking Therapeutics, For: Oct 23October 23, 2024 4:10 PM Viking Therapeutics Reports Third Quarter 2024 Financial Results and Provides Corporate UpdateOctober 23, 2024 4:05 PM Viking Therapeutics (VKTX) October 25 weekly option implied volatility bid into quarter results October 22, 2024 11:18 AM